Abstract
Approximately 25 % of mismatch repair (MMR) variants are exonic nucleotide substitutions. Some result in the substitution of one amino acid for another in the protein sequence, so-called missense variants, while others are silent. The interpretation of the effect of missense and silent variants as deleterious or neutral is challenging. Pre-symptomatic testing for clinical use is not recommended for relatives of individuals with variants classified as ‘of uncertain significance’. These relatives, including non-carriers, are considered at high-risk as long as the contribution of the variant to disease causation cannot be determined. This results in continuing anxiety, and the application of potentially unnecessary screening and prophylactic interventions. We encountered a large Irish Lynch syndrome kindred that carries the c.544A>G (p.Arg182Gly) alteration in the MLH1 gene and we undertook to study the variant. The clinical significance of the variant remains unresolved in the literature. Data are presented on cancer incidence within five kindreds with the same germline missense variant in the MLH1 MMR gene. Extensive testing of relevant family members in one kindred, a review of the literature, review of online MMR mutation databases and use of in silico phenotype prediction tools were undertaken to study the significance of this variant. Clinical, histological, immunohistochemical and molecular evidence from these families and other independent clinical and scientific evidence indicates that the MLH1 p.Arg182Gly (c.544A>G) change causes Lynch syndrome and supports reclassification of the variant as pathogenic.
Similar content being viewed by others
References
Lynch HT, de la Chapelle A (2003) Hereditary colorectal cancer. N Engl J Med 348:919–932
Peltomaki P, Vasen HF (2004) Mutations associated with HNPCC predisposition—Update of ICG-HNPCC/InSiGHT mutation database. Dis Markers 20:269–276
Plon SE, Eccles DM, Easton D, Foulkes WD, Genuardi M, Greenblatt MS, Hogervorst FBL, Hoogerbrugge N, Spurdle AB, Tavtigian SV (2008) Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat 29(11):1282–1291
Vasen HF, Mecklin JP, Khan PM, Lynch HT (1991) The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 34:424–425
Woods MO, Williams P, Careen A, Edwards L, Bartlett S, McLaughlin JR, Younghusband HB (2007) A new variant database for mismatch repair genes associated with Lynch syndrome. Hum Mutat 28(7):669–673
Ou J, Niessen RC, Vonk J, Westers H, Hofstra RMW, Sijmons RH (2008) A database to support the interpretation of human mismatch repair gene variants. Hum Mutat 29(11):1337–1341
Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S (1998) A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248–5257
Lao-Sirieix P, Caldos C, Fitzgerald RC (2010) Curr Opin Genet Dev 20:210–217
Domingo E, Laiho P, Ollikainen M, Pinto M, Wang L, French AJ, Westra J, Frebourg T, Espin E, Armengol M, Hamelin R, Yamamoto H, Hofstra RM, Seruca R, Lindblom A, Peltomaki P, Thibodeau SN, Aaltonen LA, Schwartz S Jr (2004) BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet 41:664–668
InSiGHT Database (2009) www.insight-group.org/mutations. Cited 22 July 2009
Rahner N (2009) University of Bonn, Institute of Human Genetics, Germany, personal communication
Wang Q, Desseigne F, Lasset C, Saurin JC, Navarro C, Yagci T, Keser I, Bagci H, Luleci G, Gelen T, Chayvialle JA, Puisieux A, Ozturk M (1997) Germline hMSH2 and hMLH1 gene mutations in incomplete HNPCC families. Int J Cancer 73:831–836
Wang Q, Lasset C, Desseigne F, Saurin JC, Maugard C, Navarro C, Ruano E, Descos L, Trillet-Lenoir V, Bosset JF, Puisieux A (1999) Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer. Hum Genet 105:79–85
Evans DGR (2011) Dept. of Clinical Genetics, St. Mary’s Hospital, Manchester, personal communication
Hodgson SV (2011) St. George’s Hospital, London, personal communication
Stella A, Wagner A, Shito K, Lipkin SM, Watson P, Guanti G, Lynch HT, Fodde R, Liu B (2001) A nonsense mutation in MLH1 causes exon skipping in three unrelated HNPCC families. Cancer Res 61:7020–7024
Auclair J, Buisine MP, Navarro C, Ruano E, Montmain G, Desseigne F, Saurin JC, Lasset C, Bonadona V, Giraud S, Puisieux A, Wang Q (2006) Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing. Hum Mutat 27(2):145–154
Hilbert, P. (2009) Institut de Pathologie et de Génétique, Département de Biologie Moléculaire, Gosselies, Belgium, personal communication
Eng L, Coutinho G, Nahas S, Yeo G, Tanouye R, Babaei M, Dork T, Burge C, Gatti RA (2004) Nonclassical splicing mutations in the coding and noncoding regions of the ATM Gene: maximum entropy estimates of splice junction strengths. Hum Mutat 23(1):67–76
Reese MG, Eeckman FH, Kulp D, Haussler D (1997) Improved splice site detection in genie. J Comput Biol 4(3):311–323
Brunak S, Engelbrecht J, Knudsen S (1991) Prediction of human mRNA donor and acceptor sites from the DNA sequence. J Mol Biol 220:49–65
Junop MS, Yang W, Funchain P, Clendenin W, Miller JH (2003) In vitro and in vivo studies of MutS, MutL and MutH mutants: correlation of mismatch repair and DNA recombination. DNA Repair 2:387–405
Takahashi M, Shimodaira H, Andreutti-Zaugg C, Iggo R, Kolodner RD, Ishioka C (2007) Functional analysis of human MLH1 variants using yeast and in vitro mismatch repair assays. Cancer Res 67(10):4595–4604
Ou J, Niessen RC, Lützen A, Sijmons RH, Kleibeuker JH, de Wind N, Rasmussen LJ, Hofstra RMW (2007) Functional analysis helps to clarify the clinical importance of unclassified variants in DNA mismatch repair genes. Hum Mutat 28(11):1047–1054
Chao EC, Velasquez JL, Witherspoon MSL, Rozek LS, Peel D, Ng P, Gruber SB, Watson P, Rennert G, Anton-Culver H, Lynch H, Lipkin SM (2008) Accurate classification of MLH1/MSH2 missense variants with multivarate analysis of protein polymorphisms-mismatch Repair (MAPP-MMR). Hum Mutat 29(6):852–860
Acknowledgments
The authors wish to sincerely thank the members of the families described, Dr. Eric Rosenthal at Myriad Genetics Laboratories and to acknowledge the contribution of Wilma Ormiston, T.J. Boyle, C.H. Nolan, B.J. Mehigan, R.B. Stephens, D. Flannery of St. James’s Hospital, Stephen G. Smith of the Department of Microbiology TCD, Steven G. Gray and Kathy A. Gately of the Translational Research Group, TCD, Paul. C. Smyth and Orla M. Sheils of the Dept. of Histopathology TCD, Michael O. Woods and Amanda Dohey of Memorial University of Newfoundland, Canada, Dr. Qing Wang, Unité d’Oncologie Moléculaire, Centre Léon Bérard, Lyon, France, Peter J. Holdsworth of the Dept. of General Surgery, Huddersfield Royal Infirmary, U.K, Dr. Julian W. Adlard of the Dept. of Clinical Genetics, Yorkshire Regional Genetic Service, Leeds, U.K, Nils Rahner and Verena Steinke of University of Bonn, Institute of Human Genetics, Germany, Pascale Hilbert of Institut de Pathologie et de Génétique, Département de Biologie Moléculaire, Gosselies, Belgium, Professor Gareth Evans of St. Mary’s Hospital, Manchester, U.K.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Farrell, M.P., Hughes, D.J., Berry, I.R. et al. Clinical correlation and molecular evaluation confirm that the MLH1 p.Arg182Gly (c.544A>G) mutation is pathogenic and causes Lynch syndrome. Familial Cancer 11, 509–518 (2012). https://doi.org/10.1007/s10689-012-9544-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-012-9544-4